Inventor · disambiguated record
Linda Wyatt
Also filed as: WYATT LINDA · WYATT LINDA S
9 granted patents·6 pending applications·79 citations·filing 2003–2019
88Inventor score
Files withMOSS BERNARD6ROBINSON HARRIET L2THE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES2US HEALTH2THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES1
Top patents by PatentIndex Score
15 records- 0192US9133480B2Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertion sitesMOSS BERNARD·Filed 2010·Granted Sep 15, 2015·23 cites·20 claims
- 0290US9133478B2Modified vaccinia Ankara (MVA) virus recombinants comprising heterologous coding sequences inserted into the intergenic regions between essential genesMOSS BERNARD·Filed 2007·Granted Sep 15, 2015·17 cites·23 claims
- 0388US9879231B2Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertion sitesUS HEALTH·Filed 2015·Granted Jan 30, 2018·7 cites·20 claims
- 0487US8916172B2MVA expressing modified HIV envelope, gag, and pol genesMOSS BERNARD·Filed 2011·Granted Dec 23, 2014·9 cites·4 claims
- 0587US7867982B2MVA expressing modified HIV envelope, gag, and pol genesUNIV EMORY·Filed 2008·Granted Jan 11, 2011·3 cites·2 claims
- 0685US9453239B2Recombinant MVA viruses expressing clade A/G, clade B, and clade C modified HIV env, gag and pol genesMOSS BERNARD·Filed 2005·Granted Sep 27, 2016·7 cites·16 claims
- 0785US7303754B2MVA expressing modified HIV envelope, gag, and pol genesUS HEALTH·Filed 2005·Granted Dec 4, 2007·12 cites·14 claims
- 0872US10421978B2Intergenic sites between conserved genes in the genome of modified vaccinia ankara (MVA) vaccinia virusTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2015·Granted Sep 24, 2019·1 cites·16 claims
- 0967US2015238593A1Mva expressing modified hiv envelope, gag and pol genesMOSS BERNARD·Filed 2014·Application pending·0 cites
- 1061US2004146528A1MVA expressing modified HIV envelope, gag, and pol genesFiled 2003·Application pending·0 cites
- 1159US2020071724A1Intergenic Sites Between Conserved Genes in the Genome of Modified Vaccinia Ankara (MVA) Vaccinia VirusTHE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2019·Application pending·0 cites
- 1255US2007048861A1Compositions and methods for generating an immune responseROBINSON HARRIET L·Filed 2006·Application pending·0 cites
- 1351US2011159036A1MVA expressing modified HIV envelope, GAG, and POL genesMOSS BERNARD·Filed 2007·Application pending·0 cites
- 1444US10894966B2Virus-based expression vectors and uses thereofTHE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2015·Granted Jan 19, 2021·0 cites·33 claims
- 1537US2015231227A1Compositions and methods for generating an immune responseROBINSON HARRIET L·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Linda Wyatt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →